2018 - 2019
- Categories:History
- Author:
- Origin:
- Time of issue:2019-03-09
- Views:0
(Summary description)
◆ Raising nearly 100 million yuan in Series A round financing.
◆ Launching clinical trials of a Class 1.1 new hypoglycemic drug.
◆ Receiving funding from the national major special fund during the13th Five-Year period.
2018 - 2019
(Summary description)
◆ Raising nearly 100 million yuan in Series A round financing.
◆ Launching clinical trials of a Class 1.1 new hypoglycemic drug.
◆ Receiving funding from the national major special fund during the13th Five-Year period.
- Categories:History
- Author:
- Origin:
- Time of issue:2019-03-09
- Views:0
Hoisting a sail to meet the sea


Milestones | Shengshi Taike's new generation DPP-4 inhibitor approved for market launch
Contact Us
Tel: +86-512-62956960(Recruitment)
+86-512-62956961(marketing)
E-mail:hr@cgenetech.com.cn
Copyright © 2022 CGeneTech (Suzhou, China) Co., Ltd. All rights reserved. 苏ICP备2022006552号-1 Powered by 300.cn SEO